Oliver Lagore Vanvalin Investment Group’s Avidity Biosciences RNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$19.6K	Buy	+663	New	+$19.6K	0.01%	341
2024 Q4	$19.3K	Sell	663 -1,091	-62%	-$31.7K	﹤0.01%	370
2024 Q3	$80.6K	Buy	1,754 +333	+23%	+$15.3K	0.02%	195
2024 Q2	$58K	Hold	1,421	–	–	0.02%	224
2024 Q1	$36.3K	Buy	+1,421	New	+$36.3K	0.01%	265